How to Make the Case for Fax Investment to a Skeptical Executive Team




Healthcare executives reviewing a fax investment business case on a tablet in a conference room

The challenge of making the case for fax infrastructure investment to an executive team is not that the case is weak. The challenge is that fax infrastructure investment does not tell a compelling story through the usual frameworks that technology investments use: new capability, competitive advantage, user experience improvement, or revenue generation.

Fax modernization is fundamentally a risk reduction and compliance investment. It addresses risks that are real but largely invisible until they materialize. It improves compliance posture in ways that only become visible when an audit occurs. And it eliminates operational friction that has become accepted as normal rather than recognized as unnecessary cost.

Making the case effectively means translating those real but invisible benefits into the language of risks and costs that executive teams are equipped to evaluate.

Start With the Risk the Organization Is Currently Carrying

The most compelling executive-level argument for fax infrastructure investment is a clear statement of the compliance and operational risk the organization is currently accepting by not investing. That requires doing the work to identify and quantify those risks before walking into the room.

For healthcare organizations, the risk inventory starts with HIPAA. Is the current fax infrastructure encrypting PHI in transit? Most legacy fax servers and analog machines are not. Is there a signed Business Associate Agreement with every vendor in the fax infrastructure chain? Many organizations cannot confirm this. Does the current fax infrastructure maintain a complete and searchable audit trail of all fax activity? For most organizations running legacy infrastructure, the answer is no.

Each of those is a documented HIPAA compliance gap that carries a real financial exposure. The HHS Office for Civil Rights has imposed penalties ranging from thousands to millions of dollars in enforcement actions involving inadequate PHI safeguards. The probability that any specific organization will face enforcement is not high on any given day, but the expected value of that risk, multiplied across the accumulated exposure of operating noncompliant fax infrastructure for years, is a number that belongs in an executive conversation.

The post on how fax infrastructure reflects an organization’s approach to risk provides a framework for articulating that risk to leadership.

Translate the Patient Safety Argument

For clinical executives, the patient safety framing of fax modernization is often more compelling than the compliance framing. The compliance framing is about what happens to the organization. The patient safety framing is about what happens to patients.

A lab result that fails to reach the ordering physician because a fax transmission failed silently. A referral that goes undetected because it was routed to the wrong department queue. A critical value notification that failed and was not retried because the infrastructure had no failure alerting. Each of those scenarios represents a documented failure mode of legacy fax infrastructure, and each has potential patient safety consequences.

Chief Medical Officers, Chief Nursing Officers, and quality improvement executives are the right audience for this framing. They have both the organizational authority and the institutional motivation to address patient safety risks. And framing fax modernization as a patient safety issue brings it into the category of investments that clinical leadership advocates for, not just IT requests that leadership evaluates.

The post on why fax modernization is a patient safety issue, not just an IT issue provides the clinical argument in more detail.

Build the Total Cost of Ownership Comparison

Executive teams respond to financial arguments when the numbers are specific and the comparison is fair. The financial case for fax modernization requires building a complete picture of what the current infrastructure actually costs, not just the line items that appear on invoices.

PSTN line charges are the visible cost. On-premises hardware maintenance, software licensing, IT staff time absorbed in reactive fax management, and the compliance exposure described above are the less visible costs. The post on what organizations get wrong when they try to quantify fax costs covers the complete cost inventory.

When that full picture is assembled and compared against the cost of a modern platform like Fax 2.0, which eliminates PSTN line charges, on-premises hardware, and the IT maintenance burden, the financial comparison is typically more favorable than executives expect. And that comparison does not include the compliance risk reduction, which represents additional expected value that should be noted even if it cannot be precisely quantified.

Address the Objection Before It Comes Up

The most common executive objection to fax investment is the implicit assumption that fax is going away and that investing in it is throwing good money after bad. That objection needs to be addressed directly rather than avoided.

The evidence that fax is going away does not support the assumption. Fax volume in healthcare has been stable or growing through multiple waves of digital transformation, as the post on how fax volume has changed over the last decade documents. The structural reasons fax persists, namely its universal reach and the compliance documentation it provides, have not been addressed by any current alternative. And the organizations that have made the most significant interoperability investments are also running modern enterprise fax infrastructure, not eliminating fax.

The investment being proposed is not in keeping a dying technology alive. It is in running necessary infrastructure at the standard that compliance and operations require.

Schedule a strategy call with the Lane team to discuss how to structure the business case for fax infrastructure investment at your organization.

Scroll to Top

Altera Digital Health (formerly known as Allscripts) has a proven track record of developing cutting-edge technology for healthcare systems. Lane’s Passport product is leveraged as a solution for hospitals within Altera’s ecosystem to provide faxing of lab results. With this partnership, hospitals benefit from the latest in healthcare technology, delivered by a team with years of experience in providing innovative solutions.

Lane has been an authorized partner with Clinisys (previously Sunquest) for decades. Since 1979, Clinisys has been providing diagnostic informatic solutions to laboratories and healthcare organizations. They develop, design and support a comprehensive clinical information suite for over 1200 hospitals. Clinisys is constantly evolving and pushing the boundaries of diagnostic care for pathology laboratories worldwide.